Finland
Incight Biomedical, headquartered in Finland and founded in 2025, is a promising university-based MedTech startup. The company is making strides in orthopaedic surgery with its innovative solution, JEDI, which is specifically designed for soft tissue diagnostics.
The startup’s approach to revolutionizing orthopaedic surgery is encapsulated in its slogan: "Revolutionising orthopaedic surgery through evidence-based diagnostics." By integrating cutting-edge machine learning techniques with optical spectroscopy, Incight Biomedical aims to enhance the accuracy of diagnostics and ultimately improve patient outcomes during joint repair surgeries.
The team at Incight Biomedical is a blend of researchers and orthopedic surgeons, highlighting the multidisciplinary nature essential for success in the MedTech industry. Although the company has not yet secured its last investment round or investors, its potential to optimize surgical procedures positions it as an attractive opportunity for future investment.
